Article Text

Download PDFPDF
19 A prospective study comparing histological and molecular features in predicting the risk of nodal disease in endometrial cancer
  1. Giorgio Bogani1,
  2. Jvan Casarin2,
  3. Mariangela Longo3,
  4. Ilaria Betella4,
  5. Francesco Multinu5,
  6. Fabio Ghezzi2,
  7. Nicoletta Colombo6,
  8. Giovanni Scambia7 and
  9. Francesco Raspagliesi8
  1. 1IRCCS National Cancer Institute, Milano, Italy
  2. 2Department of Obstetrics and Gynecology, Women’s and Children’s Del Ponte Hospital, University of Insubria, Varese, Italy
  3. 3Department of Obstetrics and Gynecology, Filippo Del Ponte Hospital, University of Insubria, Varese, Italy
  4. 4Department of Gynecologic Oncology, European Institute of Oncology, Milan, Italy
  5. 5Department of Gynecologic Surgery, IRCCS European Institute of Oncology, Milan, Italy
  6. 6Department of Gynecology, European Institute of Oncology, IEO, IRCCS, Milan, Italy
  7. 7Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
  8. 8Fondazione IRCCS Istituto Nazionale dei Tumori, Gynecological Oncology Unit, Milan, Italy


Introduction/Background To assess the role of histopathological and molecular features in predicting the risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing sentinel node mapping.

Methodology This is a prospective multicenter trial (Clinical trial registration: NCT05793333). Consecutive patients with apparent early-stage endometrial cancer undergoing hysterectomy, bilateral salpingo-oophorectomy, and sentinel node mapping were enrolled. Histological and molecular features were used to predict the node positivity.

Results Charts of 210 apparent early-stage endometrial cancer patients were evaluated. The study population included 178 (85%%) and 32 (15%) patients with endometrioid and non-endometrioid endometrial cancer, respectively. According to conventional pathological uterine characteristics, 94 (44%), 46 (22%), 41 (19%), and 32 (15%) were classified as low, intermediate, intermediate-high, and high-risk, respectively. According to molecular classification 10 (5%), 42 (20%), 57 (27%), and 101 (48%) were included in the POLE mutated, p53 abnormal, MMRd/MSI-H, and NSMP, respectively. Overall, 41 (19%) patients were detected with positive nodes. Pathological characteristics were more likely to predict nodal status instead of molecular features. Molecular features were not associated with the risk of having nodal metastases (OR: 1.03 (95%CI: 0.21, 5.95; p=0.969) for POLE mutated; OR: 0.788 (95%CI: 0.32, 1.98; p=0.602) for p53 abnormal; OR: 1.14 (95%CI: 0.53, 2.42); p=0.733 for MMRd/MSI-H). At multivariate analysis, only deep myometrial invasion (OR: 3.33 (95%CI: 1.40,7.80); p=0.006) and LVSI (OR: 6.03 (95%CI: 2.56, 15.4); p<0.001) correlated with nodal status. A nomogram evaluating the impact of pathological and molecular features on nodal status was built (C index: 0.810).

Conclusion Our prospective study suggested that molecular features seem not useful to tailor the need for nodal dissection in apparent early-stage endometrial cancer. Further external validation is needed.

Disclosures None.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.